June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Effects of exogenous recombinant human bone morphogenic protein-7 on the corneal wound healing
Author Affiliations & Notes
  • Jin Kwon Chung
    Ophthalmology, Soonchunhyang University College of Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea (the Republic of)
  • Footnotes
    Commercial Relationships   Jin Kwon Chung, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 161. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jin Kwon Chung; Effects of exogenous recombinant human bone morphogenic protein-7 on the corneal wound healing. Invest. Ophthalmol. Vis. Sci. 2017;58(8):161.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : We evaluated the effect of exogenous recombinant human bone morphogenic protein-7 (rhBMP-7) on transforming growth factor-β (TGF-β)-induced corneal fibrosis. and wound healing.

Methods : We evaluated epuithelai mesenchymal transition (EMT) markers such as fibronectin, E-cadherin, α-smooth muscle actin (α-SMA), and matrix metaloproteinase-9 (MMP-9). The level of corneal fibrosis and the reepithelization rate were evaluated using a rabbit keratectomy model. Keratocytes expressing α-SMA were quantified following treatment with different concentrations of rhBMP-7.

Results : Treatment with rhBMP-7 attenuated TGF-β-induced EMT. It significantly attenuated fibronectin secretion, the α-SMA protein level, and MMP-9 expression in HECEs compared with cells grown in the presence of TGF-β alone. E-cadherin expression was significantly enhanced in the presence of rhBMP-7. Topical application of rhBMP-7 combined with 0.1% HA significantly reduced the amount of α-SMA+ cells by at a concentration of 2.5 µg/ml and at a concentration of 25 µg/ml (P < 0.05 for both)), compared with the control group, without disturbing corneal reepithelization.

Conclusions : rhBMP-7 attenuates TGF-β-induced EMT in vitro, and topical application of rhBMP-7 reduces keratocyte myodifferentiation during the early wound healing stages in vivo without hindering reepithelization.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.